Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in Central Africa is experiencing significant growth and development, driven by various factors and trends in the region. Customer preferences in the Central African market for Other OTC Pharmaceuticals (Pharmacies) are influenced by several factors. Firstly, there is a growing awareness and demand for self-medication and self-care among consumers. This trend is driven by the convenience and accessibility of over-the-counter products, as well as the increasing availability of information on healthcare and wellness through digital platforms. Consumers in Central Africa are seeking products that can help them manage common health conditions and minor ailments without the need for a prescription or a visit to a healthcare professional. In addition to self-care, affordability is another important factor influencing customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Central Africa. Many consumers in the region have limited access to healthcare services and rely on over-the-counter products as a more affordable alternative to prescription medications. This affordability factor is particularly important in low-income countries in Central Africa, where healthcare expenses can be a significant burden for the population. Trends in the Other OTC Pharmaceuticals (Pharmacies) market in Central Africa are also shaped by local healthcare systems and regulations. In many countries in the region, there is a lack of access to healthcare professionals and pharmacies, especially in rural areas. This has led to the emergence of informal markets and street vendors selling over-the-counter products. While this informal sector poses challenges in terms of product quality and safety, it also presents opportunities for market growth and expansion as consumers seek convenient and accessible options for purchasing over-the-counter medications. Another trend in the market is the increasing availability of generic and private label products. Generic medications are becoming more popular among consumers in Central Africa due to their lower cost compared to branded products. This trend is driven by the need for affordable healthcare options and the presence of generic manufacturers in the region. In addition, private label products, which are typically offered by retail chains and supermarkets, are gaining traction as consumers look for trusted and cost-effective alternatives to branded products. Local special circumstances in Central Africa, such as the prevalence of certain health conditions and cultural beliefs, also influence the Other OTC Pharmaceuticals (Pharmacies) market. For example, malaria is a major health concern in the region, and there is a high demand for anti-malarial medications and preventive measures. Cultural beliefs and practices related to traditional medicine also play a role in shaping customer preferences and market dynamics. Underlying macroeconomic factors, such as population growth, urbanization, and economic development, are driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Central Africa. As the population continues to grow and urbanize, the demand for healthcare products and services is expected to increase. Economic development and rising disposable incomes are also enabling more consumers to afford over-the-counter medications and healthcare products. Overall, the Other OTC Pharmaceuticals (Pharmacies) market in Central Africa is experiencing growth and development due to customer preferences for self-care, affordability, and convenience. Trends such as the availability of generic and private label products, as well as the emergence of informal markets, are shaping the market dynamics. Local special circumstances and underlying macroeconomic factors further contribute to the growth of the market in the region.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
